ADHD Medication Changes Behavior, Not Learning
Barkley likens ADHD to diabetes, yet 64% of children move in and out of the diagnostic criteria repeatedly; medication buys compliance without improving learning, the long-term MTA follow-up confirms no academic advantage, and what actually works is small-group differentiated teaching.
The video won't play here. Listen to the audio instead:
The argument · timestamps estimated from transcript position
Barkley's own data overturn Barkley's own analogy
Barkley has long likened ADHD to diabetes and argued that it requires lifelong treatment. But in his own follow-up research, 64% of the children showed a markedly fluctuating course, moving out of the diagnostic criteria and back in again. The host points out that diabetes does not behave this way: the pancreas does not work normally for a few years and then fail, and you do not move out of a diabetes diagnosis. If ADHD really were a biological deficit in the brain, this coming and going should not happen. Yet Barkley goes on to maintain that more than 90% of people have high symptom levels for life. The two statements contradict each other outright.
— Jen LumanlanChildren's self-reports run ten times lower than their parents'
In Barkley's Milwaukee study, only 4% of participants reported enough symptoms in a diagnostic interview at age 21, while at the same time 46% of their parents reported that they did — a tenfold gap. Barkley explains the difference as young people underestimating their own symptoms, and says their reports do not become reliable until around age 30. The host offers the other reading: why could it not be the parents overestimating? The diagnostic process never genuinely asked the child about their experience in the first place. So that 4% figure may be exactly what a diagnostic system that does not trust children produces.
— Jen LumanlanThe diagnostic interview measures how much trouble the child causes parents
In the textbook Barkley edited, the questions for a child's diagnostic interview include "what did the child do that bothered you" and "how severe is this for you," rated on a scale of 1 to 9. The subject of the question is the degree to which the parent is affected by the child's behavior, not what the child feels. The same textbook also concedes that symptoms vary by setting: a high activity level is normal at recess and only becomes a problem back in the classroom. The host's challenge: if the child simply does not fit a classroom environment that demands stillness, why is the disorder located in the child rather than in the environment?
— Jen LumanlanMedication lets a child display what they know, not learn more
Barkley states plainly that the premise for using stimulants is that they "work" — their effect is to help the individual perform the knowledge they already have, not to increase the amount of knowledge. The host seizes on the logic: if medication only makes existing knowledge performable, then short-term academic scores should not rise at all; and if the hope is that the stock of knowledge grows after years on medication, Barkley then objects that the existing academic studies are too short to capture the long-term benefit. She also notes that drug companies do not advertise long-term academic gains, which is itself a signal pointing the other way.
— Jen LumanlanThe same children learned no more on medication than on placebo
Pelham's study used a crossover design in which 173 children with ADHD studied social studies, science and vocabulary units under both medication and placebo conditions. The effect on classroom behavior was enormous: 37% more arithmetic problems completed per minute, 53% fewer rule violations per hour — they looked like model students. But the knowledge tests showed that they did not learn more of the material while medicated than while on placebo, and memory did not improve either. Medication had only a small effect on immediate test scores taken while the drug was active, and that effect vanished once it wore off — a performance effect, not a learning effect.
— Jen LumanlanWhat actually got children learning was small-group teaching
The host concedes Barkley would say Pelham's classroom is not the real world, but she also identifies the crucial part: in those small groups (1 to 11 children per group, averaging 5 to 6) using evidence-based strategies such as brainstorming, think-pair-share, modeling out loud, and having students summarize and predict, the children genuinely did learn. Medication added no learning on top of good teaching. That turns it into a question of where resources go: put the money into the classroom, or keep buying drugs? Medication can raise compliance, but it cannot deliver the learning outcomes parents actually want.
— Jen LumanlanBarkley opposes letting children take part in medication decisions
Confronted with the proposal that children should have a part in medication decisions, Barkley says children have no frontal lobe and no capacity to weigh costs and benefits, and that giving a child a say is "unbelievable, absolutely ridiculous." But children describe the experience of taking the drug as: headaches, depression, friends saying I am not myself any more, becoming boring, nausea, unable to eat. The medical model demands lifelong dosing like insulin and gives the child no voice, while the person who bears the side effects every day is precisely the child.
— Dr. Barkley / Jen LumanlanFour in five children have stopped medication within five years
Discontinuation studies show that one year after starting, only 40% to 60% are still taking medication; the figure is about half among those over 12 and slightly higher for ages 4 to 11, because parents are doing the prompting. After five years only 20% of the child group remains, and about 10% of the older group. These discontinuation rates far exceed the rate at which ADHD symptoms naturally remit, which means people stop not because they have recovered but because children do not like how the drug feels, or do not see it helping with the things they themselves value. That directly contradicts the lifelong-medication narrative.
— Jen LumanlanIn their own words · checked verbatim
the majority of children in this study, 64% showed a markedly fluctuating course moving out of the diagnostic criteria
Dr. Barkley6:20
only about 4% reported enough symptoms to be diagnosed as ADHD in adulthood. However, if we interviewed your parents at that same follow-up period at age 21, the rate of disorder was 10 times higher
Dr. Barkley9:12
The use of medication for ADHD is predicated on one premise: it works.
Dr. Barkley16:09
It was a performance effect, not a learning effect.
Jen Lumanlan18:49
Medication did not make them learn more, but good teaching did.
Jen Lumanlan23:28
The idea that we would allow the child to make these decisions on their own or even to have a voice in these decisions is incredible. I mean, it's ludicrous.
Dr. Barkley25:17
Maybe they understand that sitting still and completing worksheets is not the same as learning and that being compliant is not the same as thriving.
Jen Lumanlan27:35
Figures
| Share of children with ADHD in the study showing a markedly fluctuating course | 64% | 6:20 |
| Share self-reporting enough symptoms to meet ADHD criteria at age 21 | 4% | 9:12 |
| Share of parents reporting the same 21-year-old sample met criteria | 46% (ten times the self-report figure) | 9:12 |
| Increase in arithmetic problems completed per minute while medicated | 37% | 18:49 |
| Reduction in rule violations per hour while medicated | 53% | 18:49 |
| Children followed in the MTA study | 538 children | 16:09 |
| Average increase in daily dose among MTA participants who kept taking medication | 41% | 16:09 |
| Share still taking medication one year after starting | 40-60% | 26:24 |
| Share of children still taking medication five years after starting | 20% | 26:24 |
| Share of the older age group still taking medication five years after starting | About 10% | 26:24 |
Glossary
- MTA study
- The largest randomized controlled trial of ADHD treatment to date, with 6-to-8-year follow-up.
- crossover design
- The same participants receive drug and placebo in sequence, each serving as their own control.
- DSM
- The diagnostic manual published by the American Psychiatric Association; ADHD's 18 symptom criteria come from it.
- misrecognition
- A concept proposed by ADHD researcher Andrew Ivan Brown, referring to people with ADHD being wrongly defined from the outside; covered in detail in the next episode.
How to listen
Parents still weighing whether to medicate their child, teachers who want to get the classroom environment right, and clinicians who care about the evidence base for pediatric psychiatric drugs.
The roughly 90 seconds of show advertising at the open and the subscription appeal at the end.